Current Enrolling Studies
Type 2 Diabetes with CV Events & Obesity Clinical Trial
We are seeking type 2 diabetic participants who are obese/overweight and who have had a cardiovascular (CV) event (heart attack, stroke, bypass, etc.) and at risk for additional CV events for a clinical research study.
This study is determining if the investigational medication is superior to insulin glargine in the occurrence of CV events, lowering blood sugars, and weight loss.
Participation Eligibility
- 18 years of age or older
- Have a diagnosis of type 2 diabetes
- Have an HbA1c value of 7.0% to 10.5%, inclusive (NOT on a sulfonylurea)
OR
Have an HbA1c value of 7.5% to 10.5%, inclusive (on a sulfonylurea) - Body Mass Index (BMI) ≥ 27 kg/m²
- Additional qualification criteria exist
Benefits
- Reimbursement available for time and travel
- You are provided study-related care and study drug at no cost (no health insurance required)
- You may help make a difference for yourself and for people like you
Research Study Location
Find Out If You Qualify
To learn more and find out if you qualify to participate, fill out the form below and a member of our team will be in touch to explain the available research studies.
Struggling With Type 2 Diabetes & Obesity?
There’s no question that managing Diabetes and Obesity can be frustrating; however, with additional support systems, like a clinical trial team, coping can be easier.
Why Consider a Clinical Trial?
Clinical trials are conducted to help test investigational treatments for medical conditions and to determine if these investigational treatments are safe and effective. These research studies explore ways to potentially treat, diagnose or manage symptoms for diseases with the hope that they will improve quality of life for patients. Study-related care is provided at no cost. In addition to this, participants may help contribute to finding cures that may help future generations stay healthy.